Each film-coated tablet contains rifampicin 150 mg, isoniazid 75 mg, pyrazinamide 400 mg and ethambutol HCl 275 mg.
Quadmax is a 4-drug fixed-dose combination (FDC) of antituberculosis drugs rifampicin, isoniazid, pyrazinamide and ethambutol HCl developed as per the recommendations of World Health Organization (WHO), which offers the ease of administration and facilitates patient compliance in the treatment of tuberculosis.
Other Services
Country
Account